BACKGROUND: The number of youth and adolescents (10-24 years) with HIV infection has increased substantially presenting unique challenges to effective health service delivery. METHODS: We examined routinely collected patient-level data for antiretroviral treatment (ART)-naive HIV-infected patients, aged 10-24 years, enrolled in care during 2006-2011 at 109 ICAP-supported health facilities in three provinces in Kenya. Loss to follow-up (LTF) was defined as having no clinic visit for 12 months prior to ART initiation (pre-ART) and 6 months for ART patients. Competing risk and Kaplan-Meier estimators were used to calculate LTF and death rates. Sub-distributional and Cox proportional-hazards models were used to identify potential predictors of death and LTF. RESULTS: Overall 22 832 patients were enrolled in care at 10-24 years of age, 69.5% were aged 20-24 years, and 82% were female. Median CD4(+) cell count was 332 cells/μl (interquartile range 153-561); 70.8% were WHO stage I/II. Young adolescents (10-14 years) had more advanced WHO stage and lower median CD4(+) cell count compared to youth (15-24 years) at enrollment (284 vs. 340 cells/μl; P < 0.0001). Cumulative incidence of LTF and death at 24 months for pre-ART patients was 46.1% [95% confidence interval (CI) 45.4-46.8%) and 2.1% (95% CI 1.9-2.3%), respectively. For those on ART, 32.2% (95% CI 31.1-33.3%) were LTF and 3.9% (95% CI 1.7-2.3%) died within 24 months. LTF among pre-ART and ART patients was twice as high among youth compared to young adolescents. CONCLUSION: LTF of young people with HIV in this Kenyan cohort was high and notably greater among youth compared to young adolescents. Novel strategies targeting these populations are urgently needed to improve retention.
BACKGROUND: The number of youth and adolescents (10-24 years) with HIV infection has increased substantially presenting unique challenges to effective health service delivery. METHODS: We examined routinely collected patient-level data for antiretroviral treatment (ART)-naive HIV-infectedpatients, aged 10-24 years, enrolled in care during 2006-2011 at 109 ICAP-supported health facilities in three provinces in Kenya. Loss to follow-up (LTF) was defined as having no clinic visit for 12 months prior to ART initiation (pre-ART) and 6 months for ARTpatients. Competing risk and Kaplan-Meier estimators were used to calculate LTF and death rates. Sub-distributional and Cox proportional-hazards models were used to identify potential predictors of death and LTF. RESULTS: Overall 22 832 patients were enrolled in care at 10-24 years of age, 69.5% were aged 20-24 years, and 82% were female. Median CD4(+) cell count was 332 cells/μl (interquartile range 153-561); 70.8% were WHO stage I/II. Young adolescents (10-14 years) had more advanced WHO stage and lower median CD4(+) cell count compared to youth (15-24 years) at enrollment (284 vs. 340 cells/μl; P < 0.0001). Cumulative incidence of LTF and death at 24 months for pre-ARTpatients was 46.1% [95% confidence interval (CI) 45.4-46.8%) and 2.1% (95% CI 1.9-2.3%), respectively. For those on ART, 32.2% (95% CI 31.1-33.3%) were LTF and 3.9% (95% CI 1.7-2.3%) died within 24 months. LTF among pre-ART and ARTpatients was twice as high among youth compared to young adolescents. CONCLUSION: LTF of young people with HIV in this Kenyan cohort was high and notably greater among youth compared to young adolescents. Novel strategies targeting these populations are urgently needed to improve retention.
Authors: Patricia P Gilliam; Jonathan M Ellen; Lori Leonard; Sara Kinsman; Cecilia M Jevitt; Diane M Straub Journal: J Assoc Nurses AIDS Care Date: 2010-06-11 Impact factor: 1.354
Authors: E J Abrams; J Weedon; J Bertolli; K Bornschlegel; J Cervia; H Mendez; G Lambert; T Singh; P Thomas Journal: Pediatr Infect Dis J Date: 2001-05 Impact factor: 2.129
Authors: Rashida A Ferrand; Lucia Munaiwa; John Matsekete; Tsitsi Bandason; Kusum Nathoo; Chiratidzo E Ndhlovu; Shungu Munyati; Frances M Cowan; Diana M Gibb; Elizabeth L Corbett Journal: Clin Infect Dis Date: 2010-10-01 Impact factor: 9.079
Authors: Peter MacPherson; Eleanor E MacPherson; Daniel Mwale; Stephen Bertel Squire; Simon D Makombe; Elizabeth L Corbett; David G Lalloo; Nicola Desmond Journal: J Int AIDS Soc Date: 2012-12-31 Impact factor: 5.396
Authors: Edith Apondi; John M Humphrey; Edwin Sang; Ann Mwangi; Alfred Keter; Beverly S Musick; Fred K Nalugoda; John Ssali; Elizabeth Bukusi; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Samuel Ayaya Journal: J Acquir Immune Defic Syndr Date: 2018-10-01 Impact factor: 3.731